A fond farewell to the foxglove? The decline in the use of digitalis

Journal of Cardiac Failure
Allen B Weisse

Abstract

Since William Withering's report on the foxglove in 1785, digitalis, in 1 form or another, has remained a mainstay in the treatment of congestive heart failure and as a means of rate control in atrial fibrillation. Recently, with the introduction of potent diuretics and other agents for the treatment of these conditions, there has been a deemphasis on the role of digitalis despite its therapeutic value. Continued evidence of the frequent usefulness of digitalis in both conditions suggests that this venerable drug should remain within the therapeutic armamentarium of cardiologists and other physicians.

References

Feb 27, 1964·The New England Journal of Medicine·H L BLUMGART
Sep 15, 2004·Journal of the American College of Cardiology·Elizabeth S KaufmanUNKNOWN Atrial Fibrillation Follow-up Investigation of Rhythm Management investigators

❮ Previous
Next ❯

Citations

Aug 2, 2018·American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions·Thomas F Whayne

❮ Previous
Next ❯

Related Concepts

Related Feeds

Atrial Fibrillation

Atrial fibrillation is a common arrhythmia that is associated with substantial morbidity and mortality, particularly due to stroke and thromboembolism. Here is the latest research.

Atrial Filbrillation

Atrial fibrillation refers to the abnormal heart rhythm characterized by rapid and irregular beating of the atria. Here is the latest research.

Arrhythmia

Arrhythmias are abnormalities in heart rhythms, which can be either too fast or too slow. They can result from abnormalities of the initiation of an impulse or impulse conduction or a combination of both. Here is the latest research on arrhythmias.

Related Papers

The Proceedings of the Nutrition Society
Mauro SerafiniAnna Raguzzini
Trends in Pharmacological Sciences
C P Siegers
Environmental and Molecular Mutagenesis
D Brusick, U Mengs
© 2021 Meta ULC. All rights reserved